Earnings Options Bets Flood Into ORCL, HIMS

Options markets are buzzing ahead of a packed earnings week. Oracle faces a June 12 expiry just two days out. The tech giant carries only 2.1% SI % FF. That low short base means options buyers are the primary bearish tool.

Adobe also has a June 12 expiry cluster. Short interest sits at 4.8% of free float. High availability (over 3,600%) signals little borrowing pressure. Options traders are effectively the price-discovery mechanism into earnings.

The most striking setup belongs to Hims & Hers Health. Short interest stands at 29.6% of free float — one of the highest in mid-cap healthcare. Availability is at zero. There are no shares left to borrow. Options are the only remaining short vehicle. With near-term expiries stacking through June 12 and June 18, traders appear to be using puts aggressively ahead of today's earnings print.

Summit Therapeutics tells a different story. The CEO bought shares ahead of today's results. Short interest is 22.6% of free float. Options availability sits near 107%. Call activity could spike on any positive earnings surprise.

Meanwhile, NVIDIA shows 30 active expiry dates through September. That dense options chain reflects sustained interest after the AI chip rebound seen this week across Asian and US markets. Meta also carries a rich expiry ladder through September 2026. Near-term weekly strikes are active as the NSO/WhatsApp spyware dispute adds headline risk.